AlmirallShare, a proprietary of Spanish pharmaceutical company Almirall, has launched to aim to find medical professionals to identify, validate or test new treatments for chronic immune-inflammatory diseases of the skin.
A survey conducted by the British Skin Foundation has suggested that 77% of British dermatologists agree that sunbeds should be banned in the UK.
Dermatological research and distribution company SkinMed has launched a new website, skinmed.co.uk.
An official statement released by the British College of Aesthetic Medicine (BCAM) on behalf of foundering member of BCAM Dr John Curran, has highlighted the need for better understanding of tax-related issues within the aesthetics specialty.
The annual Sclerotherapy Conference hosted by the British Association of Sclerotherapists (BAS) will take place on Tuesday May 19 next year at the Dorney Lake Conference Centre near Windsor.
Aesthetic distributor AestheticSource has announced the agenda and speakers for its Symposium taking place on September 6.
The British College of Aesthetic Medicine (BCAM) has confirmed the speakers for its 2019 annualconference on Saturday September 21 in London.
The European Investment Bank (EIB) has granted a €120 multimillion loan to Spanish pharmaceutical company Almirall under the investment plan for Europe.
The Advertising Standards Authority (ASA) has upheld its decision for skincare supplement brand Dermacoll to revoke marketing claims in regards to a collagen drink it was promoting on its website.
Dalvi Humzah Aesthetic Training (DHAT) is launching a course specifically focused on presentation skills on December 6 2019.